Jefferies Financial Group Inc.
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 96223
NEW YORK, NY
Position in XERS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$2,325,866
+$1,816,626 QoQ
Shares Held
293,670
+234.5% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#58
of 236 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $24,089,483 across 13 Drug Manufacturers - Specialty & Generic names. XERS ranks #3 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
370,092 | $9,389,234 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,697 | $3,628,635 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
293,670 | $2,325,866 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
10,630 | $1,791,580 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,304 | $1,534,899 | |
| 6 | ZTS |
Zoetis Inc.
|
18,525 | $1,331,206 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
34,027 | $1,231,777 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
27,400 | $991,880 |
All Filings in XERS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,325,866 | 293,670 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $509,240 | 87,800 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $689,230 | 87,800 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||